Home > Investor > Financial Highlights > Revenues by country

Revenues by country

Distribution of sales revenues by geographic region 
 %
Europe 34
Bulgaria  65
Other 1

The contribution of sales in Bulgaria to the consolidated sales revenue in Q3 2019 amounted to 65%, increasing by 8% compared to Q3 2018. Sopharma has a 3% share of the Bulgarian pharmaceutical market in terms of value and a 10,7% share in terms of sold quantity (units). The positions of the main competitors of the Company in the country are as follows:

  • Novartis: 7% (4% in units)
  • Roche: 6% (0.2% in units),
  • Actavis: 4.6% (10% in units)
  • GlaxoSmithKlein: 3.5% (2.7% in units)
  • Abbvie: 3,7% (0% in units)
  • Sanofi-Aventis: 2.9% (2% in units)
  • Astra Zeneca: 2.6% (0.5% in units)
  • Pfizer: 3.8% (1% in units)
  • Merck: 3.8% (1% in units)